IMR Press / EJGO / Volume 9 / Issue 2 / pii/1988029

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research

The role of cytoreduction in ovarian cancer

Show Less
1 Department of Obstetrics and Gynecology, University of Milan, Milan, Italy
2 The Netherlands Cancer Institute, Amsterdam, The Netherlands
3 Leiden University Medical Center, Leiden, The Netherlands
4 Utrecht University Medical Center, Utrecht, The Netherlands
5 Groningen University Medical Center, Groningen, The Netherlands
Eur. J. Gynaecol. Oncol. 1988, 9(2), 149–152;
Published: 10 April 1988

Whether or not cytoreduction improves the outlook of ovarian cancer patients is not yet clear from data from Literature. Maybe. not the successful procedure itself, but the favou­rable tumor characteristics of these tumors determine the prognosis. New studies are necessary to define the role of surgery in the overall management of ovarian cancer more precisely. In this article a Dutch study is presented, to answer the question about the influence of attempted cy­toreductive surgery prior to, during chemotherapy on survival time and remission rates. All patients are treated with either combination chemotherapy and/or an attempt to cytoreduction prior to or during chemotherapy. With this strategy ethical problems concerning undertreatment are avoid­ed. The study is currently activated but it is too early to draw any conclusions. 

Back to top